Daclizumab Subcutaneous and Darvon

• Generic Name: daclizumab
• Dosage Forms: n.a.
• Other Brand Names: Zinbryta, Zenapax

Daclizumab injection is used to treat the relapsing forms of multiple sclerosis (MS). Daclizumab will not cure MS, but it may slow some of the disabling effects and decrease the number of relapses of the disease. It should only be used when other medicines to treat MS did not work well.

Daclizumab was available only under a restricted distribution program called the Zinbryta® REMS (Risk Evaluation and Mitigation Strategy) Program.

Daclizumab was voluntarily withdrawn from the worldwide market on March 2, 2018 due to safety concerns.

• Generic Name: propoxyphene
• Dosage Forms: capsule
• Other Brand Names: Darvon, Darvon-N, PP-Cap

Darvocet (acetaminophen and propoxyphene) was withdrawn from the U.S. market in November 2010.

Darvocet contains a combination of propoxyphene and acetaminophen. Propoxyphene is in a group of drugs called narcotic pain relievers. Acetaminophen is a less potent pain reliever and a fever reducer that increases the effects of propoxyphene.

Darvocet is used to relieve mild to moderate pain with or without fever.

Darvocet may also be used for purposes not listed in this medication guide.